File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1177/00220345231210227
- Scopus: eid_2-s2.0-85179363440
- PMID: 38058134
- WOS: WOS:001115994600001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Ang1/Tie2/VE-Cadherin Signaling Regulates DPSCs in Vascular Maturation
Title | Ang1/Tie2/VE-Cadherin Signaling Regulates DPSCs in Vascular Maturation |
---|---|
Authors | |
Keywords | dental pulp human umbilical vein endothelial cells pericytes stem cells transforming growth factor beta 1 vascular endothelial growth factor receptor 2 |
Issue Date | 2024 |
Citation | Journal of Dental Research, 2024, v. 103, n. 1, p. 101-110 How to Cite? |
Abstract | Adding dental pulp stem cells (DPSCs) to vascular endothelial cell–formed vessel-like structures can increase the longevity of these vessel networks. DPSCs display pericyte-like cell functions and closely assemble endothelial cells (ECs). However, the mechanisms of DPSC-derived pericyte-like cells in stabilizing the vessel networks are not fully understood. In this study, we investigated the functions of E-DPSCs, which were DPSCs isolated from the direct coculture of human umbilical vein endothelial cells (HUVECs) and DPSCs, and T-DPSCs, which were DPSCs treated by transforming growth factor beta 1 (TGF-β1), in stabilizing blood vessels in vitro and in vivo. A 3-dimensional coculture spheroid sprouting assay was conducted to compare the functions of E-DPSCs and T-DPSCs in vitro. Dental pulp angiogenesis in the severe combined immunodeficiency (SCID) mouse model was used to explore the roles of E-DPSCs and T-DPSCs in vascularization in vivo. The results demonstrated that both E-DPSCs and T-DPSCs possess smooth muscle cell–like cell properties, exhibiting higher expression of the mural cell–specific markers and the suppression of HUVEC sprouting. E-DPSCs and T-DPSCs inhibited HUVEC sprouting by activating TEK tyrosine kinase (Tie2) signaling, upregulating vascular endothelial (VE)–cadherin, and downregulating vascular endothelial growth factor receptor 2 (VEGFR2). In vivo study revealed more perfused and total blood vessels in the HUVEC + E-DPSC group, HUVEC + T-DPSC group, angiopoietin 1 (Ang1) pretreated group, and vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor pretreated group, compared to HUVEC + DPSC group. In conclusion, these data indicated that E-DPSCs and T-DPSCs could stabilize the newly formed blood vessels and accelerate their perfusion. The critical regulating pathways are Ang1/Tie2/VE-cadherin and VEGF/VEGFR2 signaling. |
Persistent Identifier | http://hdl.handle.net/10722/341434 |
ISSN | 2023 Impact Factor: 5.7 2023 SCImago Journal Rankings: 1.909 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhang, Y. | - |
dc.contributor.author | Lin, S. | - |
dc.contributor.author | Liu, J. | - |
dc.contributor.author | Chen, Q. | - |
dc.contributor.author | Kang, J. | - |
dc.contributor.author | Zhong, J. | - |
dc.contributor.author | Hu, M. | - |
dc.contributor.author | Basabrain, M. S. | - |
dc.contributor.author | Liang, Y. | - |
dc.contributor.author | Yuan, C. | - |
dc.contributor.author | Zhang, C. | - |
dc.date.accessioned | 2024-03-13T08:42:47Z | - |
dc.date.available | 2024-03-13T08:42:47Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | Journal of Dental Research, 2024, v. 103, n. 1, p. 101-110 | - |
dc.identifier.issn | 0022-0345 | - |
dc.identifier.uri | http://hdl.handle.net/10722/341434 | - |
dc.description.abstract | Adding dental pulp stem cells (DPSCs) to vascular endothelial cell–formed vessel-like structures can increase the longevity of these vessel networks. DPSCs display pericyte-like cell functions and closely assemble endothelial cells (ECs). However, the mechanisms of DPSC-derived pericyte-like cells in stabilizing the vessel networks are not fully understood. In this study, we investigated the functions of E-DPSCs, which were DPSCs isolated from the direct coculture of human umbilical vein endothelial cells (HUVECs) and DPSCs, and T-DPSCs, which were DPSCs treated by transforming growth factor beta 1 (TGF-β1), in stabilizing blood vessels in vitro and in vivo. A 3-dimensional coculture spheroid sprouting assay was conducted to compare the functions of E-DPSCs and T-DPSCs in vitro. Dental pulp angiogenesis in the severe combined immunodeficiency (SCID) mouse model was used to explore the roles of E-DPSCs and T-DPSCs in vascularization in vivo. The results demonstrated that both E-DPSCs and T-DPSCs possess smooth muscle cell–like cell properties, exhibiting higher expression of the mural cell–specific markers and the suppression of HUVEC sprouting. E-DPSCs and T-DPSCs inhibited HUVEC sprouting by activating TEK tyrosine kinase (Tie2) signaling, upregulating vascular endothelial (VE)–cadherin, and downregulating vascular endothelial growth factor receptor 2 (VEGFR2). In vivo study revealed more perfused and total blood vessels in the HUVEC + E-DPSC group, HUVEC + T-DPSC group, angiopoietin 1 (Ang1) pretreated group, and vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor pretreated group, compared to HUVEC + DPSC group. In conclusion, these data indicated that E-DPSCs and T-DPSCs could stabilize the newly formed blood vessels and accelerate their perfusion. The critical regulating pathways are Ang1/Tie2/VE-cadherin and VEGF/VEGFR2 signaling. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Dental Research | - |
dc.subject | dental pulp | - |
dc.subject | human umbilical vein endothelial cells | - |
dc.subject | pericytes | - |
dc.subject | stem cells | - |
dc.subject | transforming growth factor beta 1 | - |
dc.subject | vascular endothelial growth factor receptor 2 | - |
dc.title | Ang1/Tie2/VE-Cadherin Signaling Regulates DPSCs in Vascular Maturation | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1177/00220345231210227 | - |
dc.identifier.pmid | 38058134 | - |
dc.identifier.scopus | eid_2-s2.0-85179363440 | - |
dc.identifier.volume | 103 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 101 | - |
dc.identifier.epage | 110 | - |
dc.identifier.eissn | 1544-0591 | - |
dc.identifier.isi | WOS:001115994600001 | - |